|
Daily Medical Update
Syncope
Saturday, April 25, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Academic emergency medicine : official journal of the Society for Academic Emergency Medicine (2025) - Systematic Review and Meta-analysis
Key Findings
- Across 18 publications with 510,545 participants, adverse events were higher in hospitalized patients (0.7%-43.8%) than discharged patients (0%-3.7%).
- GRADE risk ratios were >5 favoring ED discharge for adverse events and all-cause mortality at a median 30-day follow-up, although bias and heterogeneity limited certainty.
📋 Practice Implication: For low-risk ED syncope patients, discharge with appropriate follow-up remains defensible, while admission decisions should be driven by identifiable high-risk features rather than syncope alone.
|
Journal of the American College of Cardiology (2025) - Randomized Controlled Trial
Key Findings
- Vasovagal syncope recurred in 29.1% of active-stocking participants vs 34.8% of sham participants over 12 months, an absolute risk reduction of 5.7% that was not significant.
- VVS-free survival did not improve with active stockings (HR 0.81, 95% CI 0.53-1.24), and median recurrent episodes were similar at 2.5 vs 2.
📋 Practice Implication: Routine prescription of thigh-high elastic compression stockings for recurrent vasovagal syncope should be tempered, reserving them for selected adherent patients rather than presenting them as reliably preventive.
|
International journal of cardiology (2025) - Meta-analysis
Key Findings
- Pooled head-up tilt positivity was 34% with drug-free testing, increasing to 53% with isoproterenol and 62% with nitroglycerin provocation.
- Control negativity remained high at 86% for drug-free testing, 83% with isoproterenol, and 88% with nitroglycerin, supporting preserved specificity despite higher provoked yield.
📋 Practice Implication: When reflex syncope remains suspected after initial evaluation, protocol choice matters; nitroglycerin-potentiated tilt testing may improve diagnostic yield without substantially eroding control negativity.
|
JACC. Clinical electrophysiology (2025) - Randomized Clinical Trial
Key Findings
- Efficacy was 87.5% with left atrial ablation vs 90% with biatrial ablation, meeting noninferiority despite similar 12-month presyncope recurrence.
- Compared with biatrial ablation, the left atrial approach reduced procedure time by 13 minutes, x-ray dose by 5.7 mGy, ablation lesions by 4, and ablation time by 125 seconds.
📋 Practice Implication: For carefully selected refractory vasovagal syncope patients undergoing cardioneuroablation, a left atrial-only strategy may reduce procedural burden while preserving short-term efficacy.
|
Hypertension research : official journal of the Japanese Society of Hypertension (2025) - Systematic Review and Meta-analysis
Key Findings
- Intensive systolic BP control below 130 mmHg reduced recurrent stroke (RR 0.79, 95% CI 0.65-0.96) and major cardiovascular events (RR 0.86, 95% CI 0.76-0.97).
- Syncope or dizziness increased with intensive control (RR 1.30, 95% CI 1.00-1.68), although absolute cardiovascular risk reductions outweighed an absolute syncope/dizziness increase of 4 per 1,000 persons.
📋 Practice Implication: In patients with prior stroke, lower BP targets can be appropriate, but syncope prevention requires orthostatic symptom surveillance and individualized dose adjustment rather than abandoning intensive control outright.
|
|
💡
Summary
Recent syncope evidence emphasizes selective rather than reflexive intervention: low-risk ED discharge remains associated with few short-term adverse events, thigh-high compression stockings did not meaningfully prevent vasovagal recurrence, and tilt-test yield depends strongly on protocol. Procedural and medication-related data refine higher-risk decisions, with left atrial cardioneuroablation showing comparable efficacy to biatrial ablation and intensive blood-pressure targets requiring monitoring for syncope or dizziness.
|
|